comparemela.com

Latest Breaking News On - Cardiovascular research network - Page 2 : comparemela.com

Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study

Significance Statement Iron supplementation and erythropoiesis-stimulating agents (ESAs) are curr

Australia
Japan
United-states
United-kingdom
Nurminen
Southwest-finland
Finland
China
Helsinki
Eteläuomen-läi
London
City-of

NSW awards top female researchers

UNSW academics recognised for excellence in cardiovascular research

Dr Jessica Maclean awarded THANZ grant

Date Time Dr Jessica Maclean awarded THANZ grant Dr Jessica Maclean has been awarded a Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) Scientific & Education Trust Grant to further investigate novel antiplatelet strategies to enhance stroke treatment. Cardiovascular disease, which includes stroke, is a leading cause of death and disability in Australia and the world. Despite this, there is only one drug available to treat stroke caused by blood clots. This treatment, thrombolysis, has a range of side effects that means less than 15 per cent of stroke sufferers are eligible to receive it – leaving 85 per cent with limited options.

Australia
Jessica-maclean
Scientific-education-trust-grant
Development-award
Cardiovascular-research-network
New-zealand
Education-trust-grant
Research-network
Professional-development-award
ஆஸ்திரேலியா
ஜெசிகா-மக்லேந்
வளர்ச்சி-விருது

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.